Thyroid cancer Tunisia
Thyroid cancer in Tunisia at attractive prices - Diagnosis, thyroidectomy, radioactive iodine treatment and follow-up at competitive prices. With our team of experienced endocrine surgeons, endocrinologists and nuclear medicine physicians, benefit from comprehensive care according to international recommendations (ATA, ESES).
What is thyroid cancer?
Thyroid cancer is a malignant tumor that develops from the cells of the thyroid gland, located at the base of the neck. The thyroid produces hormones essential for metabolism (T3, T4, calcitonin). Thyroid cancer is relatively rare (about 1-2% of cancers) but its incidence is increasing worldwide, especially due to the fortuitous discovery of thyroid incidentalomas on ultrasound. Fortunately, most thyroid cancers (over 90%) have an excellent prognosis with a 5-year survival rate exceeding 95% for differentiated forms.
What are the different types of thyroid cancer?
Several types of thyroid cancers are distinguished. Papillary carcinoma, the most frequent (80-85%), has a good prognosis. Follicular carcinoma (10-15%) has a good prognosis but a risk of distant metastasis. Oncocytic carcinoma, a variant of follicular, has an intermediate prognosis. Medullary carcinoma (3-5%) is more aggressive, sometimes familial. Anaplastic carcinoma (1-2%) is very aggressive and has a poor prognosis. Finally, thyroid lymphoma is rare, often associated with Hashimoto's thyroiditis.
What are the signs and symptoms?
Thyroid cancer is often asymptomatic at the beginning and discovered fortuitously. Alarm signs may include a palpable thyroid nodule, even though most nodules are benign. Rapid neck swelling or enlargement of a pre-existing nodule is suspicious. Cervical lymphadenopathy, i.e., a hard and mobile or fixed lymph node, may appear. Persistent hoarseness indicates possible recurrent nerve paralysis. Dysphagia or dyspnea may occur due to tracheal compression. Neck pain or a foreign body sensation are also possible. Sometimes, diarrhea or cutaneous flushing is observed in medullary cancer, or distant metastases.
How to diagnose thyroid cancer?
The diagnosis of thyroid cancer is based on a well-codified approach. Cervical ultrasound is the key examination, assessing size, contours and microcalcifications. The EU-TIRADS score estimates the risk of malignancy. Fine needle aspiration (FNA) under ultrasound guidance is the reference examination for diagnosis. Cytological reading gives a Bethesda classification. Hormonal assessment measures TSH, T3, T4 and calcitonin. Staging includes cervical lymph node ultrasound, sometimes chest CT or bone scintigraphy. Finally, the pathology of the surgical specimen confirms the diagnosis and establishes the pTNM classification.
What is the treatment for thyroid cancer?
The management of thyroid cancer is multidisciplinary. Surgery (thyroidectomy) is the basic treatment, with lobo-isthmectomy or total thyroidectomy. Radioactive iodine treatment (131-I) destroys thyroid residues after total thyroidectomy. Lifelong substitutive hormone therapy with Levothyrox® aims to suppress TSH. External radiotherapy is rare, reserved for anaplastic cancer or inoperable recurrences. Targeted therapies, such as sorafenib or lenvatinib, are used for refractory cancers. Monitoring includes ultrasound, thyroglobulin and anti-Tg antibody assays.
How is a thyroidectomy performed?
Surgery for thyroid cancer is performed under general anesthesia. The incision is horizontal, low, in a neck fold for an aesthetic scar. The operative duration is 1h30 to 3 hours depending on the extent of the procedure. Intraoperative recurrent nerve monitoring is systematic to avoid vocal cord paralysis. Hospitalization lasts 1 to 3 days depending on the extent of the surgery. Postoperative outcomes include possible drainage for 24-48 hours and rapid resumption of feeding. A risk of hypocalcemia requires calcium supplementation if the parathyroids are damaged. The final pathological examination is available in 7-10 days.
What are the risks and possible complications?
Thyroidectomy is a safe surgery, but specific risks exist. Recurrent paralysis, leading to permanent hoarseness, occurs in less than 1-2% of cases in experienced hands. Permanent hypoparathyroidism, with calcium deficiency, requires lifelong treatment in less than 1-2% of cases. Postoperative hemorrhage, with compressive hematoma, is rare (less than 0.5%). Wound infection is rare under antibiotic prophylaxis. Transient hypocalcemia is frequent (10-30%), but generally transient. Finally, an unsightly scar, or keloid, is possible but rare.
What is the prognosis of thyroid cancer?
The prognosis is excellent for differentiated forms of thyroid cancer. 10-year survival exceeds 90% for papillary and follicular cancers. Recurrence is possible in 5-20% of cases, often cervical lymph node well controlled. For medullary cancer, 10-year survival reaches 70-80% if discovered early. In contrast, anaplastic cancer has a poor prognosis, with a median survival of less than six months. Annual follow-up with thyroglobulin assay and cervical ultrasound every 6-12 months are essential.
What is the price of thyroid cancer treatment in Tunisia?
Tunisia offers very competitive rates:
Lobo-isthmectomy: between €2,500 and €3,500.
Total thyroidectomy: between €3,000 and €4,500.
Total thyroidectomy + lymph node dissection: between €4,000 and €6,000.
Radioactive iodine treatment (hospitalization and dose): between €800 and €1,500.
Complete package (total thyroidectomy + iodine + 1-year follow-up): €5,000 to €7,500.
These prices include surgeon and anesthesiologist fees, operating room, hospitalization, basic preoperative tests, follow-up consultation and (for the package) radioactive iodine. A personalized quote will be provided after studying the file.
Why choose Tunisia for thyroid cancer?
Tunisia is a recognized destination in endocrine surgery. Endocrine surgeons are experienced, trained in France, Belgium or Canada. Intraoperative recurrent nerve monitoring is systematic to prevent complications. State-of-the-art nuclear medicine allows radioactive iodine management in protected rooms. Rates are competitive, with savings of 50-70% compared to Europe. Care is rapid, with surgery scheduled within 2-3 weeks. Personalized follow-up is provided by endocrinologists and nuclear medicine physicians. International support helps with accommodation, transfers and interpreters.
What follow-up after treatment?
Follow-up after thyroid cancer is essential and lifelong. Hormone replacement therapy with Levothyrox® is prescribed at suppressive doses according to risk. Thyroglobulin and anti-Tg antibody assays are performed every 6-12 months. Undetectable thyroglobulin indicates no recurrence. Cervical ultrasound is performed every 6-12 months for 5 years, then annually. Iodine scintigraphy or PET-CT is indicated if recurrence is suspected. Calcium monitoring is necessary after total thyroidectomy. Finally, genetic counseling is offered for familial medullary cancer (MEN2).
In conclusion
Thyroid cancer has an excellent prognosis when management is rapid and complete: accurate diagnosis, total thyroidectomy by an experienced surgeon, radioactive iodine treatment if indicated, rigorous endocrine follow-up. In Tunisia, Tunisie Esthetic offers you quality multidisciplinary care, at the best international standards and at competitive prices. Our team supports you at every stage, from diagnosis to long-term monitoring. Do not hesitate to contact us to discuss your situation and obtain a personalized quote.